The objective of the study is to assess the efficacy of the vein visualization device AccuVein (AccuVein, Inc., Huntington, NY) in comparison to a standard technique for establishing intravenous (iv) access in the infant and toddler population (\<2years)
The objective of this project is to compare the iv success rate using the FDA approved Accuvein device for vein illumination versus not using the device, for infants/toddlers undergoing surgery at Penn State Children's Hospital with an ASA physical status 1, 2, or 3. After obtaining informed consent, the infant will be randomized to the vein illuminatin or standard group based on a computer generated number.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
160
Infrared illumination of veins using the FDA approved AccuVein (AccuVein, Inc., Huntington, NY) device.
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Success Rate
Success for insertion of intravenous access line will be determined by flushability with 5 ml of sterile normal saline
Time frame: When patient is in operating room and insertion of intravenous access line has been confirmed to be successful, an average of 30 minutes
The Number of Attempts
The number of attempts it takes for successful insertion of the intravenous access line
Time frame: When patient is in operating room and insertion of intravenous access line is performed
Time to Successful Insertion
The time to successful insertion of the intravenous access line will be measured from the first time that the canula touches the skin to until successful iv access is established
Time frame: When patient is in operating room and insertion of intravenous access line is performed
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.